You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
SBIR Phase I:A Wearable, Independent, Braille-Assistive Learning Device
SBC: BRAILLEWEAR Topic: HCThe broader/commercial impact of this Small Business Innovation Research (SBIR) Phase I project is in creating an independent. assistive Braille learning device for blind people. The ability to read Braille is highly correlated with improved independence and quality of life. An estimated 70% of the blind are unemployed yet, of that subpopulation that is Braille literate, only 10% are unemployed. T ...
SBIR Phase I 2023 National Science Foundation -
SBIR Phase II:Use of ultraviolet light as a treatment for pathogens in strawberry fields
SBC: TRIC ROBOTICS INC. Topic: RThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project seeks to accelerate the transition from chemical pesticides to non-chemical alternatives by providing farmers with a sustainable, long-term solution for managing pests, while reducing agricultural impacts on human health and the environment. Today, strawberry farmers are reliant on chemical p ...
SBIR Phase II 2023 National Science Foundation -
Decarbonized Bio-based 2-Methylfuran Manufacturing in America for Sustainable Domestic Bio-Economy
SBC: RIKARBON INC Topic: C5610d2-Methylfuran (2MF) is a versatile non-food biomass derived low-carbon number performance advantaged bio-product. It is used for manufacturing green solvent (2-methyltertrahydrofuran (2MeTHF)), UpSycal?oils that RiKarbon is manufacturing for end-use natural and sustainable cosmetics and lubricants, and chemical/pharmaceutical intermediates. Currently fossil-based incumbent solvents such as tetrahy ...
SBIR Phase I 2023 Department of Energy -
Development of New Metallization Pastes for Front-Side of Tunnel Oxide Passivated Contact Crystalline Silicon Solar Cells
SBC: ADVANCED MATERIAL ANALYSIS TECHNOLOGY LLC Topic: C5615fAMA Tech is developing a cutting-edge metallization paste for the front side of tunnel oxide passivated contact (TOPCon) crystalline silicon solar cells, which is expected to improve TOPCon solar cell efficiency significantly. This development has the potential to disrupt the photovoltaic industry, as even a small increase in cell efficiency could replace current passivated emitter and rear cell ( ...
SBIR Phase I 2023 Department of Energy -
Torsional Resonator System for the Simultaneous Measurement of Density and Viscosity at High Temperature
SBC: STF TECHNOLOGIES LLC Topic: C5512cWe propose to develop a robust, accurate multi-frequency torsional resonator system for the simultaneous measurement of density and viscosity of molten salts at high temperature. The goal of the project is to develop a stand-alone resonator system that is accurate, precise and robust, and therefore can be used as the basis for a laboratory instrument as well as an on-line process monitoring sensor ...
STTR Phase I 2023 Department of Energy -
SBIR Phase I:Artificial Intelligence (AI) chatbot providing flare-up support for patients with endometriosis
SBC: Amie Health Inc Topic: DHThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is a novel chatbot that provides support to endometriosis patients. Endometriosis is a debilitating chronic pain disorder that impacts approximately one in ten women in the United States -resulting in significant loss of productivity, low quality of life, and greater than $80 billion annual ec ...
SBIR Phase I 2023 National Science Foundation -
Chemical-based Nitric Oxide Gas-generating Drug Device for the Treatment of Pulmonary Hypertension
SBC: INOVODEL, INC. Topic: NHLBISUMMARY Patients with pulmonary hypertension (PH) experience low oxygen saturation, shortness of breath, low quality of life, and a short life span (lt10 years) following diagnosis. These patients frequently present to emergency rooms, and many are admitted to intensive care units (ICUs), straining the health care system. Despite therapy with phosphodiesterase-5 inhibitors, prostacyclin analogs, a ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Increasing IDeA state Biomedical Entrepreneurship via Ecosystem, Enterprises and Experts
SBC: Insitehub LLC Topic: NIGMSSummary The proposed DE iRED program consists of university and private sector partnerships to deliver a comprehensive program that will engage and support biomedical innovators in the early stages of technology commercialization by addressing key bottlenecks in the startup process as identified both in the solicitation and by the DRIVEN Accelerator Hub. According to DRIVEN’s Voice of Customer i ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of a Small Molecule Inhibitor of Fortilin for Atherosclerosis Treatment and Prevention
SBC: FORTISCIENCE, INC. Topic: NHLBIProject Summary Project Title: Development of a Small Molecule Inhibitor of Fortilin for Atherosclerosis Treatment and Prevention. Atherosclerosis affects more than 18 million Americans and is a major cause of cardiovascular diseases and acute cardiovascular events, such as heart attack and stroke. Current interventions include changes to diet and exercise, smoking cessation, and treatment with st ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of multimode vacuum ionization for use in medical diagnostics
SBC: MSTM LLC Topic: NIAIDThere is a critical need for rapid and cost-effective means for the detection of e.g. infectious diseases at an early stage, drug overdoses, and other health related testing necessities. Thus, significant commercial opportunities exist because of the lack of these capabilities as painfully “demonstrated” in the current pandemic. Mass spectrometry (MS), because of its ability to detect hundreds ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health